{"id":354029,"date":"2019-04-11T06:45:03","date_gmt":"2019-04-11T06:45:03","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=354029"},"modified":"2019-04-11T06:45:03","modified_gmt":"2019-04-11T06:45:03","slug":"osteoporosis-drugs-market-2019-global-size-share-growth-opportunities-and-industry-forecast-by-type-price-regions-key-players-trends-and-demand-by-2023","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/osteoporosis-drugs-market-2019-global-size-share-growth-opportunities-and-industry-forecast-by-type-price-regions-key-players-trends-and-demand-by-2023_354029.html","title":{"rendered":"Osteoporosis Drugs Market 2019 Global Size, Share, Growth Opportunities and Industry Forecast by Type, Price, Regions, Key Players, Trends and Demand by 2023"},"content":{"rendered":"<div style=\" width:250px; padding:8px 10px 10px 10px; float:right;\"><a href=\"https:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2019\/04\/1554976675.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"image\" src=\"https:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2019\/04\/1554976675.jpeg\" alt=\"\" width=\"200\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\" style=\" font-weight:bold; font-style:italic;\">\n<div>&#8220;Osteoporosis Drugs Market&#8221;<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">This study covers the market dynamics and trends in major countries that are expected to influence the current market scenario and future status of the Global Osteoporosis Drugs Market over the forecast period. <\/div>\n<p>The Osteoporosis Drugs market restraints are loss of patents of block busters, greater penetration of generics and fragmentation of market, poor efficacy and side effects of present therapies, non-life threatening nature and poor symptoms of osteoporosis etc.<\/p>\n<p>Taking all the factors into consideration, we expect the global osteoporosis market which totaled ~ $10,855 million to reach 14,300 million by 2022, growing with a CAGR of 4.7%.<\/p>\n<p>The Osteoporosis Drugs market driving factors were identified to be rise in the geriatric population, increased screening, drug induced osteoporosis, alcoholism and smoking, increased awareness and focus towards female health, rising prevalence of diseases, conditions and medical procedures that may cause bone loss such as cancer, autoimmune disorders, thalassemia, hormonal disorders, modern lifestyle etc.<\/p>\n<p><strong><em>Get Free Sample Copy @ <\/em><\/strong><a rel=\"nofollow\" href=\"https:\/\/www.marketresearchfuture.com\/sample_request\/2479\"><em>https:\/\/www.marketresearchfuture.com\/sample_request\/2479<\/em><\/a><\/p>\n<p>Osteoporosis is weakening of bones due to lower bone mass resulting in and micro-architectural deterioration of bone tissue and subsequent higher risk of a broken fracture. It generally occurs at an advanced age and women are more susceptible to it than males by about three to four folds. WHO estimates that around 1.66 million hip fractures occur each year worldwide due to osteoporosis. According to national osteoporosis foundation about 54 million Americans suffer from osteoporosis.<\/p>\n<p>The disease also has a genetic bias in that it Caucasians are more affected than Asians. The disease prevalence is lowest in African population.<\/p>\n<p><strong>Key Players:<\/strong><\/p>\n<ul>\n<li>Eli Lilly and Company<\/li>\n<li>Merck &amp; Co.<\/li>\n<li>Novartis International AG<\/li>\n<li>Amgen Inc.<\/li>\n<li>F. Hoffmann La Roche Ltd.<\/li>\n<li>Pfizer Inc.<\/li>\n<li>Novo Nordisk<\/li>\n<li>Teva Pharmaceutical Industries Ltd<\/li>\n<\/ul>\n<p><strong>Segmentation:<\/strong><br \/> Global osteoporosis drugs market has been segmented on the basis of drug class which comprises bisphosphonates, calcitonin&rsquo;s, selective estrogen receptor modulators (SERMS), parathyroid hormone (PTH) and others. On the basis of route of administration; market is segmented into oral, injectable and others. On the basis of gender the market is segmented into male and female.<\/p>\n<p><strong>Regional Analysis<\/strong><br \/> Globally America is the largest market for osteoporosis drugs. Europe is the second-largest market for osteoporosis drugs. The developed regions are expected to hold their market leadership in the near future but with falling market share due to rise of Asia Pacific region which is expected to be fastest growing region in osteoporosis drugs market. The Asia pacific region will be led by China and India. Africa is expected to be a laggard in the global osteoporosis market.<\/p>\n<p><strong>Intended Audience:<\/strong><\/p>\n<ul>\n<li>Osteoporosis Drugs Manufacturers<\/li>\n<li>Osteoporosis Drugs Suppliers<\/li>\n<li>Private Research Laboratories<\/li>\n<li>Research and Development (R&amp;D) Companies<\/li>\n<li>Market Research and Consulting Service Providers<\/li>\n<li>Government Research Laboratories<\/li>\n<li>Contract Manufacturing Organizations<\/li>\n<\/ul>\n<p><strong><em>Browse Complete 84 Pages Premium Research Report Enabled with Respective Tables and Figures @&nbsp;<\/em><\/strong><a rel=\"nofollow\" href=\"https:\/\/www.marketresearchfuture.com\/reports\/osteoporosis-drugs-market-2479\"><em>https:\/\/www.marketresearchfuture.com\/reports\/osteoporosis-drugs-market-2479<\/em><\/a><\/p>\n<p><strong>Detailed Table of Contents:<\/strong><\/p>\n<p><strong>1 Introduction<\/strong><\/p>\n<p>1.1 Definition<\/p>\n<p>1.2 Scope Of Study<\/p>\n<p>1.3 Research Objective<\/p>\n<p>1.4 Assumptions &amp; Limitations<\/p>\n<p>1.5 Market Structure<\/p>\n<p><strong>2 Research Methodology<\/strong><\/p>\n<p>2.1 Research Process<\/p>\n<p>2.2 Primary Research<\/p>\n<p>2.3 Secondary Research<\/p>\n<p><strong>3 Market Dynamics<\/strong><\/p>\n<p>3.1 Drivers<\/p>\n<p>3.2 Restraints<\/p>\n<p>3.3 Opportunities<\/p>\n<p>3.4 Challenges<\/p>\n<p>3.5 Macroeconomic Indicators<\/p>\n<p><strong>4 Market Factor Analysis<\/strong><\/p>\n<p>4.1 Porter&rsquo;s Five Forces Model<\/p>\n<p>4.1.1 Bargaining Power Of Suppliers<\/p>\n<p>4.1.2 Bargaining Power Of Customer<\/p>\n<p>4.1.3 Intensity Of Competitor&rsquo;s<\/p>\n<p>4.1.4 Threat Of New Entrants<\/p>\n<p><strong>5 Global Osteoporosis Drugs Market, By Drug Class<\/strong><\/p>\n<p>5.1 Introduction<\/p>\n<p>5.2 Bisphosphonates<\/p>\n<p>5.3 Calcitonins<\/p>\n<p>5.4 Selective Estrogen Receptor Modulators (SERMs)<\/p>\n<p>5.5 Parathyroid Hormone (PTH<\/p>\n<p>5.6 Others<\/p>\n<p><strong>&hellip;TOC Continued!<\/strong><\/p>\n<p><strong><em>Send an Enquiry @ <\/em><\/strong><a rel=\"nofollow\" href=\"https:\/\/www.marketresearchfuture.com\/enquiry\/2479\"><em>https:\/\/www.marketresearchfuture.com\/enquiry\/2479<\/em><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><strong>About US:<\/strong><\/p>\n<p>Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research &amp; Consulting Services.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/marketresearchfuture.com_36734.html\" rel=\"nofollow\">Market Research Future<\/a><br \/><strong>Contact Person:<\/strong> Abhishek Sawant<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=osteoporosis-drugs-market-2019-global-size-share-growth-opportunities-and-industry-forecast-by-type-price-regions-key-players-trends-and-demand-by-2023\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +1 646 845 9312<br \/><strong>Address:<\/strong>Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar  <br \/><strong>City:<\/strong> Pune<br \/><strong>State:<\/strong> Maharashtra<br \/><strong>Country:<\/strong> India<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.marketresearchfuture.com\/reports\/osteoporosis-drugs-market-2479\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.marketresearchfuture.com\/reports\/osteoporosis-drugs-market-2479<\/a><\/p>\n<p>&nbsp;<\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=osteoporosis-drugs-market-2019-global-size-share-growth-opportunities-and-industry-forecast-by-type-price-regions-key-players-trends-and-demand-by-2023\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8220;Osteoporosis Drugs Market&#8221; This study covers the market dynamics and trends in major countries that are expected to influence the current market scenario and future status of the Global Osteoporosis Drugs Market over the forecast period. The Osteoporosis Drugs market &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/osteoporosis-drugs-market-2019-global-size-share-growth-opportunities-and-industry-forecast-by-type-price-regions-key-players-trends-and-demand-by-2023_354029.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-354029","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/354029","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=354029"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/354029\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=354029"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=354029"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=354029"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}